Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Cap Junky
- Development stage
- Unknown
- Lead developer
- DEMECAN
- Administration
- Inhalation
01
Overview
Cap Junky is a highly potent, balanced hybrid medical cannabis strain (cultivar) developed through a collaboration between breeders Capulator and Seed Junky Genetics. It is a genetic cross of Alien Cookies and Kush Mints #11. In Germany, it is imported and distributed by DEMECAN as an unirradiated medical cannabis flower under the brand names Demecan Craft Serenova 31/1 and Demecan Serenova 31/1 CJ. The strain typically features a high tetrahydrocannabinol (THC) content of approximately 31% to 32% and around 1% cannabidiol (CBD). It is prescribed for the treatment of chronic pain, sleep disorders (insomnia), and chronic stress, and is administered via inhalation using a medically approved vaporizer.
- Brand names
- Demecan Craft Serenova 31/1Demecan Serenova 31/1 CJEPIC DROP
- Other names
- Miracle Mints
02
Targets
CNR1 (Cannabinoid receptor 1)
Beyond the preview
Go deeper on Cap Junky.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Cap Junky.